In this episode of The Fellow on Call: The Heme/Onc Podcast – the group continues discussing the management of early-stage ER+/HER2-breast cancer. Specifically, they explain what types of HR+ breast cancer histology does not typically benefit from chemotherapy, what types of breast tumors do respond favorably to chemotherapy, what targeted treatment options are available for localized ER+ HER- breast cancer, and more.